Colorectal Cancer Liver Metastases : A Comprehensive Guide to Management
https://libcat.nshealth.ca/en/permalink/provcat44873
Mauro Monteiro Correia, Michael A. Choti, Flavio G. Rocha, Go Wakabayashi, editors.
--Cham:
Springer
, c2020.
- Available Online
- View e-Book
- Location
- Online
Colorectal cancer is the third most commonly diagnosed condition in oncology, affecting around 1.23 million individuals per year, according to recent statistics. Of these patients, about 50% will develop liver metastases and approximately 20% will present a stage IV disease at diagnosis. These statistics make colorectal liver metastases (CLM) an issue of major importance in current oncology. The area of CLM is subject to great and continuous advances, as its pathophysiologic mechanisms are bett…
- Available Online
- View e-Book
- Responsibility
- Mauro Monteiro Correia, Michael A. Choti, Flavio G. Rocha, Go Wakabayashi, editors
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- c2020
- Physical Description
- 1 online resource (xvii, 598 p.) : 97 illus., 67 illus. in color
- ISBN
- 9783030254865
- 9783030254858 (Print ed.)
- 9783030254872 (Print ed.)
- 9783030254889 (Print ed.)
- Subjects (MeSH)
- Colorectal Neoplasms - complications
- Liver Neoplasms - secondary
- Neoplasm Metastasis - diagnosis
- Neoplasm Metastasis - therapy
- Prognosis
- Specialty
- Gastroenterology
- Medical Oncology
- Abstract
- Colorectal cancer is the third most commonly diagnosed condition in oncology, affecting around 1.23 million individuals per year, according to recent statistics. Of these patients, about 50% will develop liver metastases and approximately 20% will present a stage IV disease at diagnosis. These statistics make colorectal liver metastases (CLM) an issue of major importance in current oncology. The area of CLM is subject to great and continuous advances, as its pathophysiologic mechanisms are better understood and more therapeutic and surgical options are developed. Consequently, all professionals involved with the diagnosis, treatment and follow up of CLM should be kept up to date with the latest advances on the field, to provide high standard medical care to their patients. This book is designed to present the state-of-the-art in CLM management and, in doing so, to review the current evidence on CLM, discussing all important topics in the field. Coverage is broad and comprehensive, encompassing introductory topics (history, definitions, epidemiology, etc.), basic science subjects (molecular biology, genetics, dissemination process, etc.) and practical clinical topics (tumor behavior, diagnosis, drug therapy, radiation therapy, surgery, ablation, multidisciplinary teams, etc.). Although comprehensive on the coverage and selection of topics, each chapter is concise and objective, dissecting topics in a practical and direct format. Evidences and recommendations are included. Chapters display a brief introduction of the common knowledge, go straight to the detailed revision of the most recent years of the literature, and end with practical closing observations. This book is a tool for professionals (general and cancer surgeons, HPB surgeons, clinical oncologists, gastroenterologists and medical residents) and interns who search for a qualified and reader friendly revision on topics concerning Colorectal Cancer Liver Metastases.
- Contents
- 1. Surgical Treatment of Colorectal Cancer Liver Metastases (CRLM) - Historical Aspects -- 2. The Biology of Colorectal Liver Metastases -- 3. Molecular Biomarkers for the Management of Colorectal Cancer Liver Metastases -- 4. Diagnosis of Colorectal Liver Metastases -- 5. Role of Imaging in the Management of Patients with Potentially Resectable CRLM -- 6. Staging Classifications of Colorectal Liver Metastases -- 7. Prognostic Factors of Colorectal Cancer Liver Metastasis -- 8. Clinical Scoring Systems for Colorectal Cancer Liver Metastases -- 9. What Is the Impact of Positive Margins in the Liver? -- 10. Multidisciplinary Team (MDT) and the Management of Colorectal Cancer Liver Metastases -- 11. Defining Resectability of Colorectal Cancer Liver Metastases: Technical and Oncologic Perspectives -- 12. Algorithms for Patients with Colorectal Liver Metastasis -- 13. Treatment Options for Resectable Colorectal Liver Metastases in the Presence of Extrahepatic Disease -- 14. Anatomical, Physiological, and Kinetic Evaluation of the Future Liver Remnant of CRLM After Portal Vein Embolisation -- 15. Systemic Therapy for Colorectal Cancer Liver Metastases: Sorting Through the Options -- 16. Neoadjuvant Chemotherapy for Resectable Colorectal Cancer Liver Metastases: Indications and Results -- 17. Management of Disappearing Liver Metastasis Following Preoperative Chemotherapy -- 18. Conversion Chemotherapy for CRLM-Best Associations, and Does Conversion Translate into Longer Survival? -- 19. Adjuvant Chemotherapy for CRLM: Indications and Results -- 20. Surgical Outcome of Colorectal Cancer Liver Metastases in Our Facility: Efficacy of Conversion Surgery in Initially Unresectable Colorectal Liver Metastases -- 21. Immunotherapy in the Management of Colorectal Cancer Liver Metastasis -- 22. Adjuvant Hepatic Arterial Infusion Therapy -- 23. Sequencing of Systemic Chemotherapy for Unresectable CRLM -- 24. Role of Hepatic Artery Infusion Pump Chemotherapy for Unresectable Colorectal Cancer Liver Metastases -- 25. Enhanced Recovery After Liver Surgery -- 26. Surgical Results for Synchronous Colorectal Cancer Liver Metastases -- 27. Resection of Metachronous Colorectal Cancer Liver Metastases: Surgical Outcomes -- 28. Laparoscopic Resections for Colorectal Cancer Liver Metastases -- 29. Robotic Partial Hepatectomy for Colorectal Cancer Liver Metastases -- 30. Navigation and Augmented Reality for Liver Surgery -- 31. Staged Hepatectomies for Colorectal Cancer Liver Metastases: When and How -- 32. Parenchymal-Sparing Surgery: What Is Behind It? -- 33. Resection of the Primary in Unresectable Colorectal Cancer Liver Metastases – Is It Worth? -- 34. Liver Pedicle Lymphadenectomy: How and When? -- 35. ALPPS for Colorectal Cancer Liver Metastases—Short and Long-Term Results -- 36. Ablative Techniques for CRLM: Alone or in Association -- 37. Chemoembolization for Colorectal Liver Metastases -- 38. Role of Y90 Radioembolization in Hepatic Metastatic Colorectal Carcinoma -- 39. Liver Transplantation for CRLM—Is It Ever Indicated? -- 40. External Radiation for Unresectable CRLM -- 41. Lessons from Collaborative Big Data—Insights from LiverMetSurvey Registry -- 42. Prognosis and Management of Recurrent Metastatic Colorectal Cancer.
- Format
- e-Book
- Location
- Online
Management of Peritoneal Metastases : Cytoreductive Surgery, HIPEC and Beyond
https://libcat.nshealth.ca/en/permalink/provcat43066
Aditi Bhatt, editor.
--Singapore:
Springer
, c2018.
- Available Online
- View e-Book
- Location
- Online
The widespread acceptance among the oncology community at large of cytoreductive surgery and HIPEC as a potentially curative treatment for peritoneal metastases has paved the way for innovative new therapies that could benefit a larger proportion of patients. Much has been and continues to be published on this subject. This book provides comprehensive reviews on the various aspects of managing peritoneal metastases. The authors highlight essential practical issues that surgical oncologists enco…
- Available Online
- View e-Book
- Other Authors
- Bhatt, Aditi
- Responsibility
- Aditi Bhatt, editor
- Place of Publication
- Singapore
- Publisher
- Springer
- Date of Publication
- c2018
- Physical Description
- 1 online resource (xi, 580 p.) : 84 illus., 32 illus. in color
- ISBN
- 9789811070532
- 9789811070525 (print ed.)
- 9789811070549 (print ed.)
- Subjects (MeSH)
- Cytoreduction Surgical Procedures - methods
- Neoplasm Metastasis - therapy
- Peritoneal Cavity - pathology
- Specialty
- Surgical Oncology
- Abstract
- The widespread acceptance among the oncology community at large of cytoreductive surgery and HIPEC as a potentially curative treatment for peritoneal metastases has paved the way for innovative new therapies that could benefit a larger proportion of patients. Much has been and continues to be published on this subject. This book provides comprehensive reviews on the various aspects of managing peritoneal metastases. The authors highlight essential practical issues that surgical oncologists encounter in their day-to-day practice, and try to before provide evidence based answers to address them. All chapters were written and/or reviewed by leading experts in this field.
- Contents
- Part I. Principles of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy -- 1. Evolving Role of CRS and HIPEC: Current Indications -- 2. Role of HIPEC in the Prevention of Peritoneal Metastasis from Colorectal, Gastric and Appendiceal Cancer -- 3. Cytoreductive Surgery for Peritoneal Metastases: Principles and Techniques -- 4. HIPEC Methodology, Comparison of Techniques, and Drug Regimens: Is There a Need for Standardization? -- 5. Early Postoperative Intraperitoneal Chemotherapy: Current Role and Future Perspectives -- 6. Imaging of Peritoneal Cancers -- 7. Diagnostic Laparoscopy for the Evaluation of Peritoneal Metastases -- 8. Combined Resection Liver Metastases and Peritoneal Metastases -- 9. Management of Complications of CRS and HIPEC -- Part II. Disease Specific Applications of Cytoreductive Surgery and HIPEC -- 10. Cytoreductive Surgery and Intraperitoneal Chemotherapy for Advanced Epithelial Ovarian Cancer -- 11. Surgical Management of Recurrent Epithelial Ovarian Cancer -- 12. Multimodality Treatment for Colorectal Peritoneal Metastases -- 13. Pseudomyxoma Peritonei Arising from Epithelial Appendiceal Tumours -- 14. Intraperitoneal Chemotherapy for Gastric Cancer -- 15. Malignant Peritoneal Mesothelioma -- 16. Rare Indications for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy -- 17. Clinical Trials in CRS and HIPEC: Ongoing Trials and Future Directives -- Part III. Beyond Cytoreductive Surgery and HIPEC -- 18. Cytoreductive Surgery and HIPEC in the Elderly -- 19. Quality of Life Issues in Patients Undergoing Cytoreductive Surgery and HIPEC -- 20. New Treatment Modalities for the Management of Peritoneal Metastases -- 21. Registries and Collaborative Groups in Peritoneal Surface Oncology -- 22. Locoregional and Palliative Therapies for Patients with Unresectable Peritoneal Metastases -- 23. Training Programs for Cytoreductive Surgery and HIPEC.
- Format
- e-Book
- Location
- Online
